Researchers have provided robust scientific evidence that ailments like depression, high blood pressure, diabetes mellitus, ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

Between 2015 and 2021, dementia incidence decreased and prevalence increased in US Medicare beneficiaries with greater burden in marginalized groups.

New research shows hearing devices do more than restore sound—they restore connection. Users report less loneliness, stronger ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

An experimental method, which can predict the aging rate of both brain and body, may detect who should implement lifestyle ...

Aging is the primary risk factor for neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

Dementia research focuses on understanding how the condition works, why it develops, and how it might be treated. Importantly, there is also a focus on how we can improve the lives of people with ...

Our research provides an update on the trajectory of dementia and highlights the significant effects of dementia research on the UK economy. We estimate that: in 2040, over 1.2 million people in the ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Worldwide, more than 55 million people are living with Alzheimer’s or another dementia, and two-thirds of Americans have at least one major potential risk factor for dementia.